Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery.
Fostel
Jennifer M
JM
D022126:Access to Information; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D015195:Drug Design; D064420:Drug-Related Side Effects and Adverse Reactions; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D043922:Toxicogenetics / Q000379:methods / Q000592:standards / Q000639:trends
D015415:Biomarkers